4//SEC Filing
OSBORN JOHN E 4
Accession 0001209191-12-031731
CIK 0001012140other
Filed
May 31, 8:00 PM ET
Accepted
Jun 1, 5:50 PM ET
Size
11.4 KB
Accession
0001209191-12-031731
Insider Transaction Report
Form 4
OSBORN JOHN E
SVP, Global Corporate Affairs
Transactions
- Award
Stock Option (Right to Buy)
2012-06-01+87,360→ 87,360 totalExercise: $44.93Exp: 2022-05-31→ Common Stock (87,360 underlying) - Award
Common Stock
2012-06-01+11,000→ 11,000 total
Footnotes (2)
- [F1]Represents restricted stock units granted to the reporting person. Each restricted stock unit represents a right to receive one share of the issuer's common stock. The restricted stock unit vests upon the meeting of certain milestones.
- [F2]Twenty-Five percent of the shares subject to the option vest and become exercisable one year from the date of grant. The remaining shares become exercisable in equal monthly installments over the following 36 months for a total vesting schedule of 48 months.
Issuer
ONYX PHARMACEUTICALS INC
CIK 0001012140
Entity typeother
Related Parties
1- filerCIK 0001209721
Filing Metadata
- Form type
- 4
- Filed
- May 31, 8:00 PM ET
- Accepted
- Jun 1, 5:50 PM ET
- Size
- 11.4 KB